tirzepatide lancet SURPASS-CVOT: Significantly Reduces Major Kidney Events Compared to Dulaglutide in T2D Effects of subcutaneous tirzepatide versus

I don't want to be old anyway, old people are ugly." READ MORE: Mum develops cancer as rare side effect from anti-cancer drug Dr Deshan Sebaratnam is a dermatologist at Liverpool Hospital and a senior lecturer at the University of New South Wales

[ [PMID: 32569680] Diabetes Care , 2020 , 43 (6), 1352-1355

Liver Fat & MASLD: A Phase 2a trial published in Nature Medicine demonstrated significant liver fat reduction and improved insulin sensitivity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), through a direct hepatic mechanism unique to Retatrutide

Key takeaways : narrow absorption window drugs, molecules with solubility-limited absorption, and therapies that need rapid onset plus sustained exposure